Exploring the Mitigation of Cross-Contamination in Shared Pharmaceutical Facilities | CPhI North America

 

View, browse and sort the ever-growing list of sessions by pass type, track, and format. With this Session Scheduler, you can build your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.

Exploring the Mitigation of Cross-Contamination in Shared Pharmaceutical Facilities

Muhammad Naeem (Chief Operating Officer, Indus Pharma Pvt. Limited)

Location: E353c

Date: Tuesday, April 30

Time: 2:15pm - 3:00pm

Vault Recording: TBD

Availability of product to patient which is Safe, Effective and Pure along with safety of operators is the biggest challenge that is being faced by Manufacturers of shared facilities around the globe. The changing industry landscape, combined with the variability of International Regulations, complicates the pharmaceutical market and calls for effective Risk Management as a means of control and oversight. So, Quality Risk Management (QRM) can provide solutions for pharmaceutical manufacturers that deal with varying regulatory challenges on an international scale.
This session will enhance participants knowledge to Identify, Analyze and Evaluate the risk of cross contamination and its quantum with respect to patient and personnel safety in shared facilities. Moreover, it will expand audience knowledge in practical application of QRM techniques, which are being used as per the cGMP and Industrial Hygiene requirements in different operational areas to manage and control risk associated with cross contamination by using the tools which are cost effective and practical without complicating the engineering solutions. All of these will propel audience to improve from within, but more importantly, the safety of patient and personnel from risk of cross contamination is utmost responsibility of all.